These findings are important because they suggest that more selective JAK inhibition, particularly targeting JAK1 or JAK2, can effectively reduce organ pathology and pathogenic IFN-γ-producing immune ...

T cells, which target infection and disease, can become more effective after a meal. The finding might help improve ...

A collaboration between the University of Geneva and Lausanne University Hospital has shown in new detail how the body's defenses fight back against malignant cells. Those defenses involve T ...

Senescent CD8+ T cells impair CAR T therapy by reducing cell growth, migration, and tumor killing, with gene signatures ...

Phase 1 study builds on early signals of anti-tumor activity in patients with refractory T and B cell lymphomasIpsoprubart, a first-in-class ...

The content creator, 26, has been participating in a clinical trial to treat her stage 4 cholangiocarcinoma, or bile duct ...

Hormones like estrogen and progesterone don’t just regulate menstrual cycles—they also shape immune responses, inflammation, and overall health. Fluctuations across the menstrual cycle, perimenopause, ...

Cytospire Therapeutics was in the spotlight this morning after announcing an oversubscribed Series A to fund a new form of ...

Citius Oncology, Inc. ("Citius Oncology" or the "Company") , a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today ...

The Argentine scientist, who discovered molecular switches that regulate the immune response, is a senior researcher at the ...

Every single type of cancer, explained A cancer diagnosis can be both terrifying and confusing for those afflicted, as well as for friends and family who don’t really know what the diagnosis means. It ...

After sharing a series of different messages about her treatment for stage four cholangiocarcinoma, influencer Sydney Towle ...